The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Aptose Biosciences Inc

TSX: LOR
Last

--

Today's change-- --
 Delayed by at least 15 minutes.
 

Aptose Biosciences Inc

TSX: LOR
Last

--

Today's change-- --
Updated January 1 -- GMT. Delayed by at least 15 minutes.

Key company metrics

  • Open--
  • Previous close--
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change--
  • Volume--
  • Average volume (10-day)--
  • Average volume (1-month)--
  • Average volume (3-month)--
  • 52-week range-- to --
  • Beta--
  • Trailing P/E--
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS--
Updated January 1 -- GMT. Delayed by at least 15 minutes.

Latest Company News

    No News Results.

Latest Press Releases

    No Press Release Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit0000
Total cost of revenue0000
Total operating expense5433
Selling / general / administrative3212
Research & development2221
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--000
Other operating expenses, total--000
Operating income-5-4-3-3
Interest income (expense), net non-operating0--00
Gain (loss) on sale of assets--------
Other--------
Income before tax-5-4-2-3
Income after tax-5-4-2-3
Income tax, total--------
Net income-5-4-2-3
Total adjustments to net income--------
Net income before extra. items-5-4-2-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-5-4-2-3
Inc. avail. to common incl. extra. items-5-4-2-3
Diluted net income-5-4-2-3
Dilution adjustment0------
Diluted weighted average shares12121212
Diluted EPS excluding extraordinary itemsvalue per share-0.42-0.33-0.20-0.22
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.42-0.33-0.20-0.22